Serum YKL-40 Predicts Relapse-Free and Overall Survival in Patients With American Joint Committee on Cancer Stage I and II Melanom

http://www.100md.com 《临床肿瘤学医学期刊》 2006年第2期

    百拇医药网 http://www.100md.com/html/DirDu/2007/04/10/41/69/87.htm

您现在查看是摘要页，全文长 33227 字符。